<DOC>
	<DOCNO>NCT00057928</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know whether cisplatin effective combine paclitaxel gemcitabine treat cervical cancer . PURPOSE : Randomized phase III trial compare effectiveness cisplatin combine paclitaxel cisplatin combine gemcitabine treat woman recurrent , persistent , metastatic cervical cancer .</brief_summary>
	<brief_title>S0227 Cisplatin With Either Paclitaxel Gemcitabine Recurrent , Persistent , Metastatic Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival , progression-free survival , objective response rate ( confirm unconfirmed , complete partial ) patient recurrent , persistent , metastatic cervical cancer treat cisplatin paclitaxel v cisplatin gemcitabine . - Compare toxicity regimens patient . OUTLINE : This randomize , multicenter study . Patients stratify accord disease status study entry ( metastatic v recurrent v persistent ) , prior cisplatin radiosensitizer ( yes v ) , extent disease ( confine pelvis vs extrapelvic disease ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive paclitaxel IV 24 hour day 1 cisplatin IV 2 hour day 2 . - Arm II : Patients receive gemcitabine IV 30 minute day 1 8 cisplatin IV 2 hour day 1 . In arm , treatment repeat every 21 day 6 course absence disease progression unacceptable toxicity . Patients follow every 3 month 2 year annually 3 year . PROJECTED ACCRUAL : A total 500 patient ( 250 per treatment arm ) accrue study within 4 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis primary carcinoma cervix , meet 1 follow stag criterion : Metastatic ( stage IVB ) Recurrent prior complete response primary treatment surgery radiotherapy Persistent surgery radiotherapy Measurable disease PATIENT CHARACTERISTICS : Age Not specify Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Creatinine less upper limit normal OR Creatinine clearance great 40 mL/min Other Not pregnant nursing Fertile patient must use effective contraception No grade 2 great sensory motor neuropathy No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy More 6 month since prior singleagent chemotherapy radiosensitizer Endocrine therapy Not specify Radiotherapy See Disease Characteristics At least 28 day since prior radiotherapy No prior radiotherapy measurable target lesion No concurrent palliative radiotherapy Surgery See Disease Characteristics Recovered prior surgery Other No prior systemic therapy No concurrent antitumor therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
</DOC>